FDA approves new drug to treat Alzheimer’s disease

The FDA approved Eli Lilly’s drug Kisunla to treat early-stage Alzheimer’s disease. Kisunla is only the second drug approved to treat the incurable disease. Medicare is expected to cover the $32,000 cost. NBC News’ Anne Thompson reports. » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Watch more NBC video: http://bit.ly/MoreNBCNews NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows. Connect with NBC News Online! NBC News App: https://apps.nbcnews.com/mobile Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621 Visit NBCNews.Com: http://nbcnews.to/ReadNBC Find NBC News on Facebook: http://nbcnews.to/LikeNBC Follow NBC News on Twitter: http://nbcnews.to/FollowNBC Follow NBC News on Instagram: http://nbcnews.to/InstaNBC #Alzheimers #FDA #EliLilly

Try Adsterra Earnings, it’s 100% Authentic to make money more and more.

NBC News